Exploring how certain microbes conduct electricity using nanowires
Understanding and using microbial conductive nanowires
This study is exploring how tiny wires made by a special bacterium can carry electricity over long distances, which could help create new medical tools and materials that improve patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10917081 on NIH RePORTER |
What this research studies
This research investigates the unique ability of microbial nanowires, specifically from the bacterium Geobacter sulfurreducens, to transport electrons over long distances. By identifying and characterizing these conductive filaments, the study aims to understand their structure and function using advanced techniques like cryogenic electron microscopy. The findings could lead to innovative applications in medicine, such as the development of biocompatible materials and biosensors that can improve patient care. Patients may benefit from advancements in medical technologies that utilize these microbial properties.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals interested in cutting-edge medical technologies and those with conditions that could be addressed by biosensors or biocompatible materials.
Not a fit: Patients with conditions unrelated to microbial technologies or those not seeking innovative medical solutions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new medical technologies that enhance diagnostics and treatment options.
How similar studies have performed: While the specific application of microbial nanowires in medicine is relatively novel, similar research in bioelectronics has shown promising results in other contexts.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Wang, Fengbin — University of Alabama at Birmingham
- Study coordinator: Wang, Fengbin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.